In this context, innovative strategies have been considered in a privileged position with its promising potential to reduce health care costs, improve patient-centered care and, thus, increase the quality of the life of the patients
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Cardiovascular diseases are the leading cause of morbidity and mortality worldwide.
📊
Key Findings & Data:Despite serious advances in the treatment options, there were 83.5 million people suffering from cardiovascular diseases in European countries in 2015 (1).
💡
Conclusion & Impact:In this context, innovative strategies have been considered in a privileged position with its promising potential to reduce health care costs, improve patient-centered care and, thus, increase the quality of the life of the patients
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters
Özet
Cardiovascular diseases are the leading cause of morbidity and mortality worldwide. Despite serious advances in the treatment options, there were 83.5 million people suffering from cardiovascular diseases in European countries in 2015 (1). In this context, innovative strategies have been considered in a privileged position with its promising potential to reduce health care costs, improve patient-centered care and, thus, increase the quality of the life of the patients
🔖
Cite This Article
HAYIROĞLU, M. İ. (2019). Telemedicine: Current Concepts and Future Perceptions. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 2, 21–22. https://ajindex.com/articles/365742
Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M, et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J 2018; 39: 508–579
Escobar-Curbelo L, Franco-Moreno AI. Application of Telemedicine for the Control of Patients with Acute and Chronic Heart Diseases. Telemed J E Health 2018 Dec 15
Cowie MR, Bax J, Bruining N, Cleland JG, Koehler F, Malik M, et al. e-Health: a position statement of the European Society of Cardiology. Eur Heart J 2016; 37: 63–6
Nguyen HH, Silva JN. Use of smartphone technology in cardiology. Trends Cardiovasc Med 2016; 26: 376–86
Krishnan A, Fuska M, Dixon R, Sable CA. The evolution of pediatric tele-echocardiography: 15-year experience of over 10,000 transmissions. Telemed J E Health 2014; 20: 681–6
Marcolino MS, Maia LM, Oliveira JAQ, Melo LDR, Pereira BLD, Andrade-Junior DF, et al. Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis. Heart 2019. pii: heartjnl-2018–314539
Marcolino MS, Santos TMM, Stefanelli FC, Oliveira JAQ, E Silva MVRS, Andrade DF Júnior, et al. Cardiovascular emergencies in primary care: an observational retrospective study of a large-scale telecardiology service. Sao Paulo Med J 2017; 135: 481–7. 8. de la Torre Díez I, Garcia-Zapirain B, Méndez-Zorrilla A, LópezCoronado M. Monitoring and Follow-up of Chronic Heart Failure: a Literature Review of eHealth Applications and Systems. J Med Syst 2016; 40: 179
Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A metaanalysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009; 54: 1683–94
Comín-Colet J, Enjuanes C, Verdú-Rotellar JM, Linas A, Ruiz-Rodriguez P, González-Robledo G, et al. Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial. J Telemed Telecare 2016; 22: 282–95
Fernandez-Moyano A, Vallejo-Maroto I, López-Jimeno W. Telehealth. N Engl J Med 2018; 378: 401–402
Brunetti ND, De Gennaro L, Correale M, Santoro F, Caldarola P, Gaglione A, et al. Pre-hospital electrocardiogram triage with telemedicine near halves time to treatment in STEMI: A meta-analysis and meta-regression analysis of non-randomized studies. Int J Cardiol 2017; 232: 5–11
Clemmensen P, Schoos MM, Lindholm MG, Rasmussen LS, Steinmetz J, Hesselfeldt R, et al. Pre-h